Article Details

Ultragenyx Announces First Patient Dosed in Pivotal Phase 2/3 Clinical Study of ...

Retrieved on: 2022-04-20 22:58:33

Tags for this article:

Click the tags to see associated articles and topics

Ultragenyx Announces First Patient Dosed in Pivotal Phase 2/3 Clinical Study of .... View article details on hiswai:

Excerpt

Details: Category: Antibodies: Published on Wednesday, 20 April 2022 18:52 ... Setrusumab is a fully human monoclonal antibody that inhibits ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up